The average one-year price target for Precigen (NasdaqGS:PGEN) has been revised to $9.69 / share. This is an increase of 11.76% from the prior estimate of $8.67 dated March 25, 2026.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $9.09 to a high of $10.50 / share. The average price target represents an increase of 135.19% from the latest reported closing price of $4.12 / share.
What is the Fund Sentiment?
There are 190 funds or institutions reporting positions in Precigen. This is an decrease of 88 owner(s) or 31.65% in the last quarter. Average portfolio weight of all funds dedicated to PGEN is 0.22%, an increase of 167.01%. Total shares owned by institutions increased in the last three months by 2.97% to 137,110K shares. 
The put/call ratio of PGEN is 0.66, indicating a bullish outlook.
What are Other Shareholders Doing?
Patient Capital Management holds 18,673K shares representing 5.28% ownership of the company. In its prior filing, the firm reported owning 26,461K shares , representing a decrease of 41.70%. The firm decreased its portfolio allocation in PGEN by 13.54% over the last quarter.
Point72 Asset Management holds 13,724K shares representing 3.88% ownership of the company. In its prior filing, the firm reported owning 2,741K shares , representing an increase of 80.03%. The firm increased its portfolio allocation in PGEN by 325.11% over the last quarter.
Tang Capital Management holds 5,618K shares representing 1.59% ownership of the company. In its prior filing, the firm reported owning 12,400K shares , representing a decrease of 120.74%. The firm decreased its portfolio allocation in PGEN by 26.14% over the last quarter.
Geode Capital Management holds 4,462K shares representing 1.26% ownership of the company. In its prior filing, the firm reported owning 3,849K shares , representing an increase of 13.75%. The firm increased its portfolio allocation in PGEN by 42.48% over the last quarter.
Diametric Capital holds 3,847K shares representing 1.09% ownership of the company. In its prior filing, the firm reported owning 974K shares , representing an increase of 74.68%. The firm increased its portfolio allocation in PGEN by 262.60% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
